#United States #Los Angeles #L Catterton #US Fertility #Amulet Capital

Strategic Growth in Fertility Care

In a groundbreaking announcement, US Fertility, the leading fertility services platform in the United States, revealed a strategic partnership with L Catterton and Amulet Capital Partners. This collaboration aims to accelerate growth and expand access to advanced reproductive healthcare for individuals and couples across the nation.

A Strong Partnership for Growth

With L Catterton recognized as the largest global consumer-focused private equity firm and Amulet Capital, a respected partner in healthcare investment, this new alliance emphasizes US Fertility’s commitment to a physician-led model that enhances clinical excellence and prioritizes patient care. The revised ownership structure allows both L Catterton and Amulet to act as co-lead investors while ensuring that US Fertility’s physician partners maintain significant ownership in the organization.

Richard Jennings, the Chief Executive Officer of US Fertility, expressed optimism about the future, stating, "With Amulet increasing its investment and L Catterton joining as a partner, we are better positioned than ever to expand access to fertility care." US Fertility has seen remarkable growth over the past five years, now supporting over 60,000 new patients annually in their journey towards parenthood.

Leading the Way in Reproductive Technology

Since its partnership with Amulet was established, US Fertility has become a premier platform offering comprehensive assisted reproductive technology (ART) services. These services include not just in vitro fertilization (IVF) and intrauterine insemination (IUI), but also genetic testing, cryogenic storage, and various ancillary offerings.

The organization prides itself on a physician-centric culture supported by a dedicated research division that drives advancements in reproductive medicine, ensuring that the best practices are upheld within clinical settings. Today, US Fertility boasts the largest network of fertility specialists and embryologists, providing top-tier care from over 120 clinic and IVF laboratory locations.

Commitment to Innovation

Jay Rose, Managing Partner at Amulet Capital Partners, highlighted the importance of continuing to provide high-quality, patient-centered care. By leveraging Amulet’s expertise in healthcare investments, both firms can drive the mission of making reproductive healthcare more accessible while supporting clinical research and innovation efforts.

Rajan Shah, a Partner at L Catterton, added, "Our partnership will help us expand access to advanced reproductive care and support the company’s mission to deliver an innovative, patient-centered experience across the U.S."

L Catterton’s extensive global network and operational resources are expected to significantly bolster US Fertility’s mission, enhancing collaboration among physicians, scientists, and care teams in the field of reproductive medicine.

A Bright Future Ahead

With a solid foundation built over the years, US Fertility is well-poised to continue its upward trajectory in the fertility care industry. The firm’s commitment to innovation, clinical excellence, and patient-focused service positions it as a leader in the space. This partnership not only signifies a substantial financial commitment but also reflects a shared vision among the stakeholders involved, dedicated to transforming reproductive healthcare for countless families across the nation.

As more individuals and couples seek assistance in their path to parenthood, US Fertility looks forward to leading the charge with innovative solutions and expanded access to state-of-the-art reproductive services. This collaborative effort marks the beginning of an exciting new chapter for US Fertility as it enhances its existing offerings and further supports the community in their family-building endeavors.